Analysis MEDINET Co., Ltd. (2370)
5/31/2024
Analysis of MEDINET Co., Ltd. (2370)
MEDINET Co., Ltd. (symbol: 2370) has been showing some fluctuations in its stock price recently. The RSI indicator has been hovering around 40-50, indicating a neutral to slightly bearish sentiment in the market. The MACD indicator has been negative, suggesting a bearish trend, but the MACD histogram has shown some signs of improvement in the last few days.The moving averages (SMA, EMA, WMA) have been relatively close to each other, indicating a lack of strong trend direction. The stock price has been trading within a range, with some volatility but no clear trend.
Overall, MEDINET Co., Ltd. seems to be in a consolidation phase, with mixed signals from technical indicators. Traders and investors may want to wait for more clarity in the price action before making any significant trading decisions.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year.
Overall, the analysts are predicting a moderate growth in sales for both the upcoming quarters and the next fiscal year. It indicates a positive outlook for the company's revenue performance in the near future.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical average. However, the company is still projected to experience solid growth over the next few years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average forecast at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, the quarter ending on August 1, 2024, had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 15.31 billion float shares and 99.29 million shares shorted. The stock has 15.33 billion shares outstanding, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65.
The stock price summary includes a beta of 1.264, 50-day moving average of $176.26, 200-day moving average of $181.04, and a 52-week range of $164.08 to $199.62.
Lastly, dividends and splits information indicates a payout ratio of 14.93%, with a dividend date on May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The company has a forward annual dividend rate of $1, a 5-year average dividend yield of 0.73%, and a trailing annual dividend yield of 0.51%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in sales from FY 2022 to FY 2023.
- Prior to the decrease, there was a consistent growth in sales from FY 2020 to FY 2022.
- FY 2022 had the highest sales figure among the four fiscal years.
- There was a significant increase in sales from FY 2020 to FY 2021.
These trends indicate fluctuations in the company's revenue over the years, with both growth and decline periods.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. Current assets have fluctuated but generally increased, with the highest value in 2023 at $143.6 billion.
3. Non-current assets have also shown an increasing trend, reaching $209 billion in 2023.
4. Total liabilities have been increasing steadily, from $248 billion in 2019 to $290.4 billion in 2023.
5. Shareholders' equity has shown some fluctuations but has increased overall, from $90.5 billion in 2018 to $62.1 billion in 2023.
6. The company has been relying more on non-current liabilities to finance its operations, as seen in the increasing trend of non-current liabilities.
7. The company has been investing more in non-current assets, such as investments and advances, which have been increasing over the years.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show significant fluctuations, especially in common stock repurchases and long-term debt issuances.
5. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
6. The end cash position has been fluctuating, but generally, the company has maintained a healthy cash balance.
7. The company has been paying dividends consistently, with varying amounts each year.
8. Stock-based compensation has also been significant, indicating employee incentives through stock options.
9. Overall, the company's financial health seems stable, with some fluctuations in cash flow and activities over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year. The estimates range from $1.44 to $1.63, based on projections by 25 analysts.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, an increase from the EPS of $6.13 in the previous year. The analysts' estimates range from $6.43 to $6.92, with insights provided by 39 analysts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a range of estimates between $6.40 and $7.90. This compares to the EPS of $6.59 in the previous fiscal year, as projected by 39 analysts.
Overall, the analysts are forecasting an increase in earnings per share for both the upcoming quarters and the next fiscal years, indicating positive growth expectations for the company.
MACD of 2370
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
